ICL Group Ltd. — Board/Management Information 2015

Aug 31, 2015

6-K 1 dp59264_6k.htm FORM 6-K

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of August, 2015

Commission File Number: 001-13742

ISRAEL CHEMICALS LTD.

(Exact name of registrant as specified in its charter)

Israel Chemicals Ltd.

Millennium Tower

23 Aranha Street

P.O. Box 20245

Tel Aviv, 61202 Israel

(972-3) 684-4400

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F X Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Yes No X

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Yes No X

Field: Rule-Page

Field: /Rule-Page Field: Page; Sequence: 1

Field: /Page

ISRAEL CHEMICALS LTD.

1. Immediate Report regarding Extension of Tenure of Dr. Miriam Haran as Member of the Company's Board of Directors.

Field: Page; Sequence: 2

Field: /Page

Item 1

August 31, 2015

Extension of Tenure of Dr. Miriam Haran as Member of the Company's Board of Directors

The Company wishes to report that according to the shareholders' decision dated February 26, 2015 (reported on the same date, reference number 2015-02-040210), the tenure of Dr. Miriam Haran as an external director, is extended for an additional three-year term commencing on September 1, 2015.

Dr. Haran also qualifies as an independent director under the NYSE's rules.

Field: Page; Sequence: 3

Field: /Page

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

/s/ Kobi Altman
Name:	Kobi Altman
Title:	Executive Vice President and Chief Financial Officer

/s/ Lisa Haimovitz
Name:	Lisa Haimovitz
Title:	Vice President, General Counsel and Corporate Secretary

Date: August 31, 2015